Medical Information
Gulf Countries
 

This medical information website is intended only for healthcare professionals in the following Gulf Countries (UAE, Oman, Bahrain, Qatar and Kuwait). This information is not intended as medical advice. Responsibility for patient care resides with the healthcare professional on the basis of his or her professional license, experience and knowledge of the patient.

Please choose the category that best describes you.

I am a Healthcare Professional registered to practice in UAE or Oman or Bahrain or Qatar or KuwaitYes, I am a Healthcare Professional registered to practice in UAE or Oman or Bahrain or Qatar or Kuwait
SelectI am a Healthcare Professional registered to practice in UAE or Oman or Bahrain or Qatar or KuwaitYes, I am a Healthcare Professional registered to practice in UAE or Oman or Bahrain or Qatar or Kuwait
I am a patient / caregiverNo, go back to the patient portal
SelectI am a patient / caregiverNo, go back to the patient portal
I am a Healthcare Professional in another country.

Congress Materials

The information on this page pertains to select congresses, congress materials, therapeutic and disease areas. It is not intended to serve as a comprehensive overview of all congresses, congress materials, therapeutic and disease areas.
Poster
Jonathan I. Silverberg, Mark Boguniewicz, Kim Papp, Athanasios Tsianakas, Pinaki Biswas, Claire Feeney, Mark Levenberg February 28, 2022 AAAAI 2022 Atopic Dermatitis

Efficacy of Abrocitinib Rescue Therapy in the Phase 3 Study JADE REGIMEN

View Presentation
Oral Presentation
Erman Guler, Peter Anderson, Simran Marwaha, James Piercy, David Gruben, Andrey Lvov, Magdalena Trzeciak, Magdalena Czarnecka-Operacz March 29, 2022 AAD 2022 Atopic Dermatitis

Atopic Dermatitis Treatment Patterns and Patient Burden in Russia and Poland

View Presentation
Oral Presentation
Raj Chovatiya, Maria Concetta Fargnoli, Brett King, Vivian Shi, Christian Vestergaard, Luis Puig, Pinaki Biswas, Marco DiBonaventura, Mark Levenberg, Claire Clibborn March 29, 2022 AAD 2022 Atopic Dermatitis

Characteristics of the Efficacy Response Trajectory Among Patients Who Did Not Flare During the Maintenance Phase of JADE REGIMEN

View Presentation
Oral Presentation
Andrew F. Alexis, Zakiya P. Rice, Kenji Kabashima, Paula C. Luna, Jacob P. Thyssen, Magdalena Trzeciak, Pinaki Biswas, Gary L. Chan, Erman Guler, Mark Levenberg March 29, 2022 AAD 2022 Atopic Dermatitis

Efficacy and Safety of Abrocitinib According to Geographies

View Presentation
Oral Presentation
Amy Paller, Lawrence F. Eichenfield, Michael J Cork, Christine Bangert, Alan D. Irvine, Stephan Weidinger, Susan Johnson, Irina Lazariciu, Herwig Koppensteiner March 29, 2022 AAD 2022 Atopic Dermatitis

Integrated Analysis of Abrocitinib for the Treatment of Adolescents with Moderate-to-Severe Atopic Dermatitis From the Phase 3 Clinical Trial Program

View Presentation
Oral Presentation
Joy Wan, Daniel B Shin, Maha N Syed, Katrina Abuabara, Adina R Lemeshow, Joel M Gelfand March 29, 2022 AAD 2022 Atopic Dermatitis

Malignancy risk among children and adults with atopic dermatitis in a population-based cohort

View Presentation
Oral Presentation
Melinda J Gooderham, Mark G Lebwohl, Eric L Simpson, Andreas Wollenberg, Andrew G Bushmakin, Joseph C Cappelleri, Marco DiBonaventura, Ricardo Rojo, Melissa Watkins, Hernan Valdez, Daniela E Myers March 29, 2022 AAD 2022 Atopic Dermatitis

Time to Improvement in Daily Signs and Symptoms Associated With Atopic Dermatitis (AD) in Patients With Moderate-to-Severe AD in Pooled Monotherapy Studies of Abrocitinib

View Presentation
Poster
Silverberg J, Thyssen J, Lazariciu I, Valdez H, Myers D, Guler E, Chovatiya R September 10, 2022 EADV 2022 Atopic Dermatitis

Abrocitinib Improves Itch and Quality of Life in Patients With Itch-Dominant Atopic Dermatitis

View Presentation
Poster
Thyssen J, Bewley A, Ständer S, Castro C, Misery L, Kim B, Biswas P, Chan G, Myers D, Watkins M, Alderfer J, Guler E, Silverberg J September 10, 2022 EADV 2022 Atopic Dermatitis

Abrocitinib Improves Skin Pain and Quality of Life Outcomes in Adolescents and Adults With Moderate-to-Severe Atopic Dermatitis

View Presentation
Oral Presentation
Guttman-Yassky E, Weidinger S, Bissonette R, Armstrong A, Seneschal J, Eyerich K, Estrada Y, Pavel A, Xu D, Chen A, Tatulych S, Guler E, Chan G, Page K, Kerkmann U, Valdez H September 10, 2022 EADV 2022 Atopic Dermatitis

Abrocitinib Reduces the Levels of Key Biomarkers Associated With Atopic Dermatitis in the Skin of Patients With Moderate-to-Severe Atopic Dermatitis

View Presentation